Cita APA (7a ed.)
PALMER, W. J. (2018). Seborrheic keratosis Tx: FDA-approved Eskata is a first for this common condition. Dermatology Times, 39(9), 69-70.
Cita Chicago Style (17a ed.)
PALMER, WHITNEY J. "Seborrheic Keratosis Tx: FDA-approved Eskata Is a First for This Common Condition." Dermatology Times 39, no. 9 (2018): 69-70.
Cita MLA (9a ed.)
PALMER, WHITNEY J. "Seborrheic Keratosis Tx: FDA-approved Eskata Is a First for This Common Condition." Dermatology Times, vol. 39, no. 9, 2018, pp. 69-70.
Precaución: Estas citas no son 100% exactas.